Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 31 Jan 2025

Structural engineering of stabilized, expanded epitope nanoparticle vaccines for HPV

in Vaccines and Molecular Therapeutics

Michaela Helble
Xizhou Zhu
Pratik S. Bhojnagarwala
Kevin Liaw
Yangcheng Gao
Amber Kim
Kelly Bayruns
Madison E. McCanna
Joyce Park
Kylie M. Konrath

Frontiers in Immunology

doi 10.3389/fimmu.2025.1535261

1,865 views

Original Research

Published on 31 Jan 2025

Adjuvant-free, self−assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses

in Vaccines and Molecular Therapeutics

Yongqiang Zhao
Shuangshuang Guo
Jia Liu
Yating Wang
Bo Wang
Chun Peng
Enqi Du

Frontiers in Immunology

doi 10.3389/fimmu.2025.1519866

1,971 views

Original Research

Published on 31 Jan 2025

Next-generation sequencing and immuno-informatics for designing a multi-epitope vaccine against HSV-1-induced uveitis

in Vaccines and Molecular Therapeutics

He Cao
Zhi Cao
Yue Han
Jing Shan

Frontiers in Immunology

doi 10.3389/fimmu.2025.1461725

1,640 views

Original Research

Published on 28 Jan 2025

Designing a broad-spectrum multi-epitope subunit vaccine against leptospirosis using immunoinformatics and structural approaches

in Vaccines and Molecular Therapeutics

Guneswar Sethi
Young Kyu Kim
Su-Cheol Han
Jeong Ho Hwang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1503853

1,894 views
1 citation

Original Research

Published on 28 Jan 2025

In silico design of a multi-epitope vaccine against Mycobacterium avium subspecies paratuberculosis

in Vaccines and Molecular Therapeutics

Weiqi Guo
Xinyu Wang
Jiangang Hu
Beibei Zhang
Luru Zhao
Guangdong Zhang
Jingjing Qi
Zuzhang Wei
Yanqing Bao
Mingxing Tian

Frontiers in Immunology

doi 10.3389/fimmu.2025.1505313

1,325 views
1 citation

Original Research

Published on 28 Jan 2025

Fusion protein-based COVID-19 vaccines exemplified by a chimeric vaccine based on a single fusion protein (W-PreS-O)

in Vaccines and Molecular Therapeutics

Pia Gattinger
Luibov I. Kozlovskaya
Alexander S. Lunin
Olga S. Gancharova
Dina I. Sirazova
Vasiliy D. Apolokhov
Egor S. Chekina
Ilya V. Gordeychuk
Alexander V. Karaulov
Rudolf Valenta

Frontiers in Immunology

doi 10.3389/fimmu.2025.1452814

1,226 views

Original Research

Published on 27 Jan 2025

Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera

in Vaccines and Molecular Therapeutics

Thomas E. Hickey
Uma Mudunuri
Heidi A. Hempel
Troy J. Kemp
Nancy V. Roche
Keyur Talsania
Brian A. Sellers
James M. Cherry
Ligia A. Pinto

Frontiers in Immunology

doi 10.3389/fimmu.2024.1502458

5,602 views

Original Research

Published on 22 Jan 2025

CoviWall, a whole-virion-inactivated B.1.617.2 vaccine candidate, induces potent humoral and Th1 cell response in mice and protects against B.1.617.2 strain challenge in Syrian hamsters

in Vaccines and Molecular Therapeutics

Jyotsna Dandotiya
Neeta Adhikari
Manas Ranjan Tripathy
Kamini Jakhar
Sudipta Sonar
Dibya Ranjan Pati
Vibhu Kanchan
Varsha S. Prasad
Jitendra Kumar
Nitesh K. Senapati

Frontiers in Immunology

doi 10.3389/fimmu.2024.1447962

1,351 views

Original Research

Published on 22 Jan 2025

Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination

in Vaccines and Molecular Therapeutics

Maaweya Awadalla
Halah Z. AlRawi
Rahaf A. Henawi
Fawziya Barnawi
Haitham Alkadi
Ahmed Alyami
Ammar Alsughayir
Alyazeed S. Alsaif
Ayman Mubarak
Wael Alturaiki

Frontiers in Immunology

doi 10.3389/fimmu.2025.1526444

1,528 views
1 citation

Brief Research Report

Published on 20 Jan 2025

Lymphoma patients treated with anti-CD20 and chemotherapy display disconnected T and B cell responses to COVID-19 vaccine

in Vaccines and Molecular Therapeutics

Sylvain Lamure
Houria Hendel Chavez
Marie-Ghislaine de Goër de Herve
Luc-Matthieu Fornecker
Bernard Drenou
Caroline Jacquet
Fatiha Merabet
Milena Kohn
Florence Quélin
Angela Jackson

Frontiers in Immunology

doi 10.3389/fimmu.2024.1524813

1,118 views

Original Research

Published on 20 Jan 2025

Brucella suis ΔmapB outer membrane vesicles as an acellular vaccine against systemic and mucosal B. suis infection

in Vaccines and Molecular Therapeutics

Florencia Muñoz González
Magali G. Bialer
Maria L. Cerutti
Silvia M. Estein
Lila Y. Ramis
Pablo C. Baldi
Ángeles Zorreguieta
Mariana C. Ferrero

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501791

2,023 views

Original Research

Published on 20 Jan 2025

Serological cross-reactivity between Crimean-Congo haemorrhagic fever virus and Nairobi sheep disease virus glycoprotein C

in Vaccines and Molecular Therapeutics

Emmanuel A. Maze
George Booth
Georgina Limon
Sandra Belij-Rammerstorfer
Simona R. Tchakarova
Tsviatko Alexandrov
Clare Browning
Ginette Wilsden
Anna B. Ludi
Bryan Charleston

Frontiers in Immunology

doi 10.3389/fimmu.2024.1423474

1,304 views

Original Research

Published on 17 Jan 2025

Aspartate aminotransferase to platelet ratio correlates with poor prognosis and metabolic alterations in Dabie bandavirus infection

in Vaccines and Molecular Therapeutics

Chunxia Guo
Ruixue Li
Xia Wang
Xiulan Peng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1471511

957 views

Editorial

Published on 16 Jan 2025

Editorial: Immune studies of SARS-CoV2 and vaccines using preclinical modeling

in Vaccines and Molecular Therapeutics

Cordelia Dunai
Smita S. Iyer
William J. Murphy

Frontiers in Immunology

doi 10.3389/fimmu.2024.1548624

866 views

Original Research

Published on 14 Jan 2025

Impact of SARS-CoV-2 vaccination and of seasonal variations on the innate immune inflammatory response

in Vaccines and Molecular Therapeutics

Hend Jarras
Isalie Blais
Benjamin Goyer
Wilfried W. Bazié
Henintsoa Rabezanahary
Mathieu Thériault
Kim Santerre
Marc-André Langlois
Jean-François Masson
Joelle N. Pelletier

Frontiers in Immunology

doi 10.3389/fimmu.2024.1513717

875 views

Original Research

Published on 14 Jan 2025

Comparison of immune responses to SARS-CoV-2 spike following Omicron infection or Omicron BA.4/5 vaccination in kidney transplant recipients

in Vaccines and Molecular Therapeutics

Inga Tometten
Tobias Brandt
Maike Schlotz
Ricarda Stumpf
Sinje Landmann
Marta Kantauskaite
Joshua Lamberti
Jonas Hillebrandt
Lisa Müller
Margarethe Kittel

Frontiers in Immunology

doi 10.3389/fimmu.2024.1476294

1,187 views